Synonyms:pindolol, 13523-86-9, Visken, Betapindol, Prinodolol, Carvisken, Durapindol, Pinbetol, Calvisken, Decreten, Pectobloc, Pynastin, LB-46, Blocklin L, Glauco-visken, Pindololum, Blocklin-L, DL-Pindolol, Blockin L, LB 46, (rs)-pindolol, 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol, 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol, 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol, Apo-pindol, 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol, 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol, 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole, 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-, Dl-lb-46, 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol, BJ4HF6IU1D, NSC-757276, 2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-, CHEBI:8214, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol, DTXSID8023476, 2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-, Glauco-Viskin, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol, NCGC00015786-11, 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol, 2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-, (+-)-Pindolol, Pindololum [INN-Latin], DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole, DTXCID603476, Blocklin, Carvisken (TN), SMR000059120, Blocklin-L (TN), Visken (TN), CCRIS 9215, HSDB 6539, SR-01000000027, EINECS 236-867-9, EINECS 244-623-8, UNII-BJ4HF6IU1D, BRN 1536506, DL-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE, DL-LB 46, Prestwick_397, CAS-13523-86-9, Pindolol [USAN:USP:INN:BAN:JAN], Spectrum_001109, (-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol, (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol, PINDOLOL [HSDB], PINDOLOL [USAN], PINDOLOL [INN], PINDOLOL [JAN], PINDOLOL [MI], PINDOLOL [VANDF], (.+/-.)-Pindolol, Prestwick0_000090, Prestwick1_000090, Prestwick2_000090, Prestwick3_000090, Spectrum2_001285, Spectrum3_000547, Spectrum4_000479, Spectrum5_001266, PINDOLOL [MART.], CHEMBL500, GTPL91, PINDOLOL [USP-RS], PINDOLOL [WHO-DD], PINDOLOL,(-), P 0778, P-6820, SCHEMBL5219, Lopac0_000955, Oprea1_770884, (+/-)-PINDOLOL, BSPBio_000020, BSPBio_002193, KBioGR_000958, KBioSS_001589, 5-21-03-00017 (Beilstein Handbook Reference), MLS000069496, MLS002548891, DivK1c_000837, SPECTRUM1500488, Pindolol (JP17/USP/INN), SPBio_001289, SPBio_001959, PINDOLOL [ORANGE BOOK], 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, BPBio1_000022, PINDOLOL [EP MONOGRAPH], 1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol, PINDOLOL [USP MONOGRAPH], HMS502J19, KBio1_000837, KBio2_001589, KBio2_004157, KBio2_006725, KBio3_001693, NINDS_000837, 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-, HMS1568A22, HMS1920H16, HMS2089I21, HMS2091P20, HMS2095A22, HMS3259I07, HMS3262P12, HMS3267K17, HMS3369E14, HMS3414J03, HMS3678H21, HMS3712A22, HMS3742C07, HMS3885N04, Pharmakon1600-01500488, VISKAZIDE COMPONENT PINDOLOL, HY-B0982, Pindolol, >=98% (TLC), powder, Tox21_110221, Tox21_500955, BDBM50019443, CCG-39223, NSC757276, PDSP1_000771, PDSP1_000772, PDSP2_000759, PDSP2_000760, (+/-)-Pindolol-d7(iso-propyl-d7), AKOS015969756, PINDOLOL COMPONENT OF VISKAZIDE, Tox21_110221_1, CS-4473, DB00960, LP00955, NC00467, NSC 757276, SB17015, SDCCGSBI-0050929.P005, IDI1_000837, NCGC00015786-06, NCGC00015786-07, NCGC00015786-08, NCGC00015786-09, NCGC00015786-10, NCGC00015786-13, NCGC00015786-14, NCGC00015786-16, NCGC00015786-20, NCGC00015786-22, NCGC00024925-03, NCGC00024925-04, NCGC00024925-05, NCGC00024925-06, NCGC00024925-07, NCGC00261640-01, BS-42390, SBI-0050929.P004, 4-(3-Isopropylamino-2-hydroxypropoxy)indole, AB00052072, EU-0100955, FT-0673907, SW196641-3, (+/-)-LB-46, C07445, C90604, D00513, AB00052072-11, AB00052072_12, AB00052072_13, 1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol, EN300-18518413, L000006, Q418101, 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDOLE, SR-01000000027-2, SR-01000000027-4, SR-01000000027-5, SR-01000000027-7, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol, BRD-A97701745-001-05-3, BRD-A97701745-001-09-5, 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #, Pindolol, European Pharmacopoeia (EP) Reference Standard, (+/-)-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol), Pindolol, United States Pharmacopeia (USP) Reference Standard, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol), N-(2-HYDROXY-3-(1H-INDOL-4-YLOXY)PROPYL)-N-ISOPROPYLAMINE
Pubchem:PUBCHEM:4828
Id:20863dbc-d3e4-5cba-9bcd-e84ed239e344
Description:nan